These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1683487)

  • 1. Diltiazem suppresses quinpirole-induced oral stereotypies in haloperidol withdrawn rats.
    Pucilowski O; Eichelman B
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(5):717-22. PubMed ID: 1683487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D1 receptor stimulation but not dopamine D2 receptor stimulation attenuates haloperidol-induced behavioral supersensitivity and receptor up-regulation.
    Marin C; Chase TN
    Eur J Pharmacol; 1993 Feb; 231(2):191-6. PubMed ID: 8095897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of apomorphine administration on rearing activity of control and experimental rats withdrawn from long-term haloperidol treatment.
    Bernardi MM; Palermo-Neto J
    Gen Pharmacol; 1984; 15(4):363-5. PubMed ID: 6541605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT; Brooderson RJ; White FJ
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic naloxone administration on vacuous chewing movements and catalepsy in rats treated with long-term haloperidol decanoate.
    Egan MF; Ferguson JN; Hyde TM
    Brain Res Bull; 1995; 38(4):355-63. PubMed ID: 8535858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin E attenuates the development of haloperidol-induced dopaminergic hypersensitivity in rats: possible implications for tardive dyskinesia.
    Gattaz WF; Emrich A; Behrens S
    J Neural Transm Gen Sect; 1993; 92(2-3):197-201. PubMed ID: 8369109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia.
    Gordon JH; Diamond BI
    Biol Psychiatry; 1981 Apr; 16(4):365-71. PubMed ID: 7194695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in behavioral sensitivity to SKF-38393 and quinpirole following withdrawal from continuous cocaine administration in rats.
    Neisewander JL; Lucki I; McGonigle P
    Pharmacol Biochem Behav; 1996 Apr; 53(4):935-42. PubMed ID: 8801600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diltiazem suppresses apomorphine-induced fighting and pro-aggressive effect of withdrawal from chronic ethanol or haloperidol in rats.
    Pucilowski O; Kostowski W
    Neurosci Lett; 1988 Oct; 93(1):96-100. PubMed ID: 3211374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen in experimental tardive dyskinesia.
    Gordon JH; Borison RL; Diamond BI
    Neurology; 1980 May; 30(5):551-4. PubMed ID: 7189262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theophylline, adenosine receptor antagonist prevents behavioral, biochemical and neurochemical changes associated with an animal model of tardive dyskinesia.
    Bishnoi M; Chopra K; Kulkarni SK
    Pharmacol Rep; 2007; 59(2):181-91. PubMed ID: 17556796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats.
    Haleem DJ; Samad N; Haleem MA
    Pharmacol Biochem Behav; 2007 May; 87(1):115-21. PubMed ID: 17498786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.
    Delfs JM; Kelley AE
    Neuroscience; 1990; 39(1):59-67. PubMed ID: 1982467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J; Devanand DP; Carey RJ
    Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
    Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
    Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment. Extrapyramidal syndromes and dopaminergic supersensitivity.
    Lublin H; Gerlach J; Peacock L
    Psychopharmacology (Berl); 1993; 112(2-3):389-97. PubMed ID: 7871047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haloperidol- and SCH23390-induced dopaminergic supersensitivities are not additive in the rat.
    Parashos SA; Barone P; Marin CA; Paraschos AJ; Kapitzoglou-Logothetis V; Chase TN
    Psychopharmacology (Berl); 1989; 98(2):189-92. PubMed ID: 2569216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monosialoganglioside (GM1) attenuates the behavioural effects of long-term haloperidol administration in supersensitive rats.
    Perry JC; Vital MA; Frussa-Filho R; Tufik S; Palermo-Neto J
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):127-33. PubMed ID: 15013028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinpirole hydrochloride, a potential anti-parkinsonism drug.
    Koller W; Herbster G; Anderson D; Wack R; Gordon J
    Neuropharmacology; 1987 Aug; 26(8):1031-6. PubMed ID: 3309709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.